/

Society

Bo

Not verified

Boehringer Ingelheim

What we write about

Advertising / Marketing / Media / CommunicatiImpreseIndustriaMedical Health WellnessPharmaceuticals

4 Press releases

View all press releases

03/09/2025

Boehringer Ingelheim Launches Swine Vaccine With Advanced Protection Against Porcine Circovirus Type 2 in the United States

Source

Boehringer Ingelheim

Issuer

1.00

0

Press Release cover image

22/11/2024

Pharmaceuticals

Sanità

Economics

Start-up

Boehringer Ingelheim launches VETMEDIN® Solution (pimobendan oral solution), first oral solution approved by the FDA for congestive heart failure in dogs

Source

Boehringer Ingelheim

Issuer

1.00

0

07/10/2024

Pharmaceuticals

Medical Health Wellness

Boehringer receives U.S. FDA Breakthrough Therapy designation and initiates two phase III trials in MASH for survodutide

Source

Boehringer Ingelheim

Issuer

1.00

0

16/09/2024

Pharmaceuticals

Medical Health Wellness

Boehringer’s nerandomilast meets primary endpoint in pivotal phase-III FIBRONEER™-IPF study

Source

Boehringer Ingelheim

Issuer

1.00

0

Followers

0

Compatibility

0